REDDICK ANDREW D

Director at ACURA PHARMACEUTICALS, INC · on record since May 23, 2008
President and CEO at ACURA PHARMACEUTICALS, INC · on record since Dec 23, 2005

Insider trading activity of REDDICK ANDREW D

Transactions on record: 15; since Aug 13, 2004

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 6, 2011

Figures computed from official regulatory filings — .

Companies where REDDICK ANDREW D has traded

ACURA PHARMACEUTICALS, INC15 tx · $2.3M · Apr 6, 2011

Track record of REDDICK ANDREW D

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of REDDICK ANDREW D

Co-insiders of REDDICK ANDREW D

Abuse Deterrent Pharma, LLCACURA PHARMACEUTICALS, INC
Azad DavidACURA PHARMACEUTICALS, INC
Boehm GarthACURA PHARMACEUTICALS, INC
Brzeczko Albert WACURA PHARMACEUTICALS, INC
CARE CAPITAL II LLCACURA PHARMACEUTICALS, INC
CARE CAPITAL INVESTMENTS II LPACURA PHARMACEUTICALS, INC
Care Capital Offshore Investments II LPACURA PHARMACEUTICALS, INC
CLAUDIUS LLCACURA PHARMACEUTICALS, INC
CLEMENS PETER AACURA PHARMACEUTICALS, INC
EMIGH JAMES FACURA PHARMACEUTICALS, INC
ESSEX WOODLANDS HEALTH VENTURES FUND V LLCACURA PHARMACEUTICALS, INC
ESSEX WOODLANDS HEALTH VENTURES FUND V LPACURA PHARMACEUTICALS, INC
GALEN EMPLOYEE FUND III LPACURA PHARMACEUTICALS, INC
Galen Management, LLCACURA PHARMACEUTICALS, INC
GALEN PARTNERS III L PACURA PHARMACEUTICALS, INC
GALEN PARTNERS INTERNATIONAL III L PACURA PHARMACEUTICALS, INC
GCE Holdings LLCACURA PHARMACEUTICALS, INC
Jones Robert BACURA PHARMACEUTICALS, INC
Markham Richard JACURA PHARMACEUTICALS, INC
Ramsay David RussACURA PHARMACEUTICALS, INC
REICHER MICHAEL KACURA PHARMACEUTICALS, INC
Rivet J BradleyACURA PHARMACEUTICALS, INC
ROSS GEORGE KACURA PHARMACEUTICALS, INC
Schutte JohnACURA PHARMACEUTICALS, INC
Seiser Robert AACURA PHARMACEUTICALS, INC
SKELLY WILLIAM GACURA PHARMACEUTICALS, INC
SMITH ALAN JACURA PHARMACEUTICALS, INC
SPIVEY RON JACURA PHARMACEUTICALS, INC
SUMNER WILLIAMACURA PHARMACEUTICALS, INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ACURA PHARMACEUTICALS, INCListing on record	Apr 6, 2011	Other	-37,500	3.90 USD	$146.3K	Unusual size	SEC
ACURA PHARMACEUTICALS, INCListing on record	Apr 6, 2011	Other	-30,263	3.90 USD	$118K	Unusual size	SEC
ACURA PHARMACEUTICALS, INCListing on record	Apr 6, 2011	Exercise	112,500	1.30 USD	$146.3K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Apr 6, 2011	ExerciseD (derivative)	-112,500	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 4, 2011	Other	-93,038	3.31 USD	$308K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 20, 2010	AwardD (derivative)	83,333	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Nov 25, 2009	Exercise	425,000	1.30	$552.5K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Nov 25, 2009	Other	-119,658	4.26	$509.7K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Nov 25, 2009	ExerciseD (derivative)	-425,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Nov 25, 2009	Other	-129,695	4.26	$552.5K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Apr 27, 2009	AwardD (derivative)	250,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Apr 27, 2009	Award	85,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	May 23, 2008	AwardD (derivative)	250,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 23, 2005	Award	8,250,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 13, 2004	AwardD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ACURA PHARMACEUTICALS, INCListing on record	Apr 6, 2011	Other	-37,500	3.90 USD	$146.3K	Unusual size	SEC
ACURA PHARMACEUTICALS, INCListing on record	Apr 6, 2011	Other	-30,263	3.90 USD	$118K	Unusual size	SEC
ACURA PHARMACEUTICALS, INCListing on record	Apr 6, 2011	Exercise	112,500	1.30 USD	$146.3K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Apr 6, 2011	ExerciseD (derivative)	-112,500	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 4, 2011	Other	-93,038	3.31 USD	$308K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 20, 2010	AwardD (derivative)	83,333	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Nov 25, 2009	Exercise	425,000	1.30	$552.5K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Nov 25, 2009	Other	-119,658	4.26	$509.7K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Nov 25, 2009	ExerciseD (derivative)	-425,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Nov 25, 2009	Other	-129,695	4.26	$552.5K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Apr 27, 2009	AwardD (derivative)	250,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Apr 27, 2009	Award	85,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	May 23, 2008	AwardD (derivative)	250,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 23, 2005	Award	8,250,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 13, 2004	AwardD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC